Differences in observed COVID-19 case fatality rates between different racial groups in the US

In a recent study posted to the medRxiv* preprint server, researchers assessed the disparities in coronavirus disease 2019 (COVID-19) case fatality rates (CFRs) among different races in the United States (US).

Study: Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population. Image Credit: emojoez/Shutterstock
Study: Racial/Ethnic Disparities in the Observed COVID-19 Case Fatality Rate Among the U.S. Population. Image Credit: emojoez/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

During the initial year of the COVID-19 pandemic, racial disparities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated deaths garnered substantial interest. However, it is unclear whether inconsistencies in mortality rates were due to differences in COVID-19 incidence, CFRs, or both.

Among US residents, minorities such as Latinx and Afro-Americans/Blacks had significantly higher COVID-19 incidence and mortality rates than Whites. However, CFRs of Blacks were only slightly greater than that of Whites. This finding indicated that disparities in COVID-19 death rates were due to discrepancies in infection rates.

It had also been observed that although COVID-19 incidence was higher among Hispanics and Blacks, the associated deaths were low and similar to Whites after the data were adjusted for sex, age, and urban/rural geographical location.

Some studies observed that while the probability of hospital admissions was twice as high for Blacks than Whites, the in-hospital COVID-19 mortality was identical to that of Whites. While the COVID-19-associated hospitalization odds were equivalent among Hispanics, Whites, and Blacks, mortality rates were higher among hospitalized Whites. Thus, although multiple studies assessed the racial disparities in COVID-19 incidence and mortality in the US, the results have not been uniform.

About the study

The present study examined differences in SARS-CoV-2 infection CFRs among US residents of different races such as Americans, Latinx, Whites, and African Americans/Blacks from March 2020 to February 2021.

The Centers for Disease Control and Prevention (CDC) COVID-19 Case Surveillance Public Use and The Atlantic’s COVID Tracking Project (CTP) datasets were used for CFR estimation. While CDC data facilitated age adjustments, the COVID racial data tracker of the CTP enabled comparison between different races.

Age-stratified and overall CFRs were used for comparison between Whites and the minorities. Only 38 states that reported deaths, as well as cases, were included for CFR estimation. Additionally, a model of monthly COVID-19 deaths was used for CFR ratio estimation after data adjustment for gender, age, time, and states.

CFRs values denoted the proportion of COVID-19 deaths compared to the reported cases. State-wise CFRs of different races were derived, and an overall national CFR value was estimated using the random-effects model. The mixed-effects Poisson model was used for CFR estimation post data adjustment for age, state, time, and gender for individuals aged 18 years and above. The I2 statistic was used to determine heterogeneity in the study population.

Results and discussion

Both datasets showed an identical pattern in the CFRs over time, with the CTP curve trailing behind the CDC curve by about 1–2 months. Significantly higher CFRs were observed for individuals 65 years and above (13.5%) as compared to those aged 18–49 years (0.1%) and 50–64 years (0.8%), respectively.

The extent of cases among individuals younger than 65 years was greater among Latinx (93%) and Blacks (89%) compared to Whites (80%). The disparities were even greater for the cases below 50 years (78% for Latinx and 69% for Blacks as opposed to 58% for Whites). Age stratified, state-wise CFRs were averagely higher among 50-64 and 18-49 age groups among Latinx and Blacks than Whites. The comparative CFRs of Blacks with Whites were 2.1, 0.9, and 3.9 for age groups 50–64, 65 and above, and 18–49 years, respectively. The corresponding CFRs of Latinx with Whites were 9.8, 3.0, and 0.9, respectively.

Significant inter-state variability was observed in both datasets in CFRs and CFR ratios between different races. The inter-state and intra-state variance values were 0.31 and 0.26, respectively. A 67% intra-state rise in CFR was noted within a month. CFRs comparing females to males was 0.76. An overall I2 value greater than 95% indicated sample heterogeneity.

Conclusion

To summarize, the overall COVID-19 CFRs in the US were higher for Whites compared to Latinx and Blacks; the age-adjusted CFRs were greater among the minorities aged below 65 years. CFRs significantly varied across the states and time.

The study findings highlight the need to develop healthcare policies tailored to the racial groups based on their COVID-19 case fatality disparities.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 11 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Pooja Toshniwal Paharia

Written by

Pooja Toshniwal Paharia

Pooja Toshniwal Paharia is an oral and maxillofacial physician and radiologist based in Pune, India. Her academic background is in Oral Medicine and Radiology. She has extensive experience in research and evidence-based clinical-radiological diagnosis and management of oral lesions and conditions and associated maxillofacial disorders.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Toshniwal Paharia, Pooja Toshniwal Paharia. (2023, May 11). Differences in observed COVID-19 case fatality rates between different racial groups in the US. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20220307/Differences-in-observed-COVID-19-case-fatality-rates-between-different-racial-groups-in-the-US.aspx.

  • MLA

    Toshniwal Paharia, Pooja Toshniwal Paharia. "Differences in observed COVID-19 case fatality rates between different racial groups in the US". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20220307/Differences-in-observed-COVID-19-case-fatality-rates-between-different-racial-groups-in-the-US.aspx>.

  • Chicago

    Toshniwal Paharia, Pooja Toshniwal Paharia. "Differences in observed COVID-19 case fatality rates between different racial groups in the US". News-Medical. https://www.news-medical.net/news/20220307/Differences-in-observed-COVID-19-case-fatality-rates-between-different-racial-groups-in-the-US.aspx. (accessed November 24, 2024).

  • Harvard

    Toshniwal Paharia, Pooja Toshniwal Paharia. 2023. Differences in observed COVID-19 case fatality rates between different racial groups in the US. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20220307/Differences-in-observed-COVID-19-case-fatality-rates-between-different-racial-groups-in-the-US.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients